Tech Company Financing Transactions

CFD Therapeutics Funding Round

CFD Therapeutics closed a $8.6 million investment round on 3/31/2006. Backers included Apjohn Ventures.

Transaction Overview

Company Name
Announced On
3/31/2006
Transaction Type
Venture Equity
Amount
$8,564,100
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
343 Oyster Point Blvd.
South San Francisco, CA 94080
USA
Email Address
Overview
The company is developing novel cancer therapeutics stemming from discoveries made previously by diaDexus. CFD will specifically focus on the development of therapeutic monoclonal antibodies directed against proprietary ovarian, pancreatic, breast, colon, prostate and lung cancer targets licensed from diaDexus.
Profile
CFD Therapeutics LinkedIn Company Profile
Social Media
CFD Therapeutics Company Twitter Account
Company News
CFD Therapeutics News
Facebook
CFD Therapeutics on Facebook
YouTube
CFD Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Executive Vice President
Jackie Papkoff
  Jackie Papkoff LinkedIn Profile  Jackie Papkoff Twitter Account  Jackie Papkoff News  Jackie Papkoff on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/31/2006: Metabolix venture capital transaction
Next: 3/31/2006: StarPound Technologies venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to record every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary